A Director at Cutera (NASDAQ: CUTR) is Buying Shares


Today, a Director at Cutera (NASDAQ: CUTR), Gregory Barrett, bought shares of CUTR for $201.5K.

Following this transaction Gregory Barrett’s holding in the company was increased by 15.89% to a total of $1.41 million.

See today’s analyst top recommended stocks >>

Based on Cutera’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $34.13 million and GAAP net loss of $2.03 million. In comparison, last year the company earned revenue of $29.3 million and had a GAAP net loss of $1.02 million. CUTR’s market cap is $477.8M and the company has a P/E ratio of 17.99. Currently, Cutera has an average volume of 657.7K.

Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $60.00, reflecting a -37.6% downside. Five different firms, including Gabelli and Griffin, currently also have a Buy rating on the stock.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cutera, Inc. is a global medical device company, which engages in the design, development, manufacture, marketing and servicing of laser and other energy based aesthetics systems for practitioners. Its products include Enlighten, TruSculpt, Excel HR, Excel V, and Xeo. The company was founded in August 1998 and is headquartered in Brisbane, CA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts